SCHEMBL16351591

SCHEMBL16351591

O=COC1CC(C(=O)O)C(CC(=O)O)C1OC=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.37
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ SLC1A2 P43004 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ GRIK1 P39086 1/20 0.32
▸ GRM5 P41594 1/20 0.32
▸ GRIA1 P42261 1/20 0.32
▸ GRIA2 P42262 1/20 0.32
▸ GRIA3 P42263 1/20 0.32
▸ GRIA4 P48058 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ GRIK2 Q13002 1/20 0.32
▸ GRIK3 Q13003 1/20 0.32
▸ GRIK4 Q16099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14944771 0.80 GABRR1 (0.40) MEN1KMT2ATSHRSLC1A2ALDH1A1
SCHEMBL12221569 0.78 GABRR1 (0.32) GABRR1
SCHEMBL12221572 0.78 GABRR1 (0.32) GABRR1
SCHEMBL16351627 0.75 HSD11B1 (0.37) HSD11B1SLC6A12SLC6A11SLC6A13
SCHEMBL14944723 0.75 GABRR1 (0.36) SLC1A2GABRR1GABRR2
SCHEMBL12364331 0.72 GABRR1 (0.37) MEN1KMT2ASLC1A2LMNAGRM5
SCHEMBL16522346 0.72 HSD11B1 (0.35) HSD11B1
SCHEMBL16351616 0.70 HSD11B1 (0.33) HSD11B1
SCHEMBL16351613 0.70 HSD11B1 (0.33) HSD11B1
SCHEMBL16351598 0.69 GABRR1 (0.34) SLC1A2GABRR1GABRR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150056367-A1 COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT SOKI CORPORATION (JP) 2015-02-26 — — US disclosed
US-20140378645-A1 LIQUID CRYSTAL ALIGNING AGENT WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378645-A1 LIQUID CRYSTAL ALIGNING AGENT CYP17A1, AUP1, NR5A1 HSD11B1 224/4885MEN1 2038/4885KMT2A 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback